(NASDAQ: FRMM) Forum Markets's forecast annual revenue growth rate of 197.5% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 41.97%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.53%.
Forum Markets's revenue in 2026 is $10,771,000.On average, 5 Wall Street analysts forecast FRMM's revenue for 2026 to be $178,093,405, with the lowest FRMM revenue forecast at $135,975,562, and the highest FRMM revenue forecast at $251,862,326. On average, 5 Wall Street analysts forecast FRMM's revenue for 2027 to be $1,339,561,233, with the lowest FRMM revenue forecast at $627,345,998, and the highest FRMM revenue forecast at $1,732,361,925.
In 2028, FRMM is forecast to generate $2,246,988,908 in revenue, with the lowest revenue forecast at $2,144,565,071 and the highest revenue forecast at $2,328,294,427.